Sol-Gel Technologies (SLGL) Invested Capital (2016 - 2025)
Sol-Gel Technologies (SLGL) reported Invested Capital of $22.8 million for Q4 2025, down 20.93% year-over-year from $28.8 million in Q4 2024, and down 20.93% quarter-over-quarter from $28.8 million in Q4 2024.
Sol-Gel Technologies (SLGL) Invested Capital (2016 - 2025) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of Invested Capital data on file, last reported at $22.8 million in Q4 2025.
- Invested Capital for Q4 2025 came in at $22.8 million, down 20.93% year-over-year; the trailing twelve-month figure through Dec 2025 was $22.8 million (down 20.93% YoY), and the FY2025 annual result was $22.8 million, down 20.93% from the prior year.
- Invested Capital slipped to $22.8 million in Q4 2025 per SLGL's latest filing, from $28.8 million in the prior quarter.
- Over five years, Invested Capital peaked at $55.6 million in Q4 2021 and troughed at $22.8 million in Q4 2025.
- A 5-year average of $37.6 million and a median of $38.6 million in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2021 and 2024: Invested Capital advanced 9.33% in 2021, then dropped 25.34% in 2024.
- A 5-year view of Invested Capital shows it stood at $55.6 million in 2021, then fell by 24.07% to $42.2 million in 2022, then retreated by 8.45% to $38.6 million in 2023, then retreated by 25.34% to $28.8 million in 2024, then decreased by 20.93% to $22.8 million in 2025.
- Business Quant data shows SLGL's Invested Capital at $22.8 million in Q4 2025, $28.8 million in Q4 2024, and $38.6 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.81 Mn |
| Dec 31, 2024 | 28.85 Mn |
| Dec 31, 2023 | 38.64 Mn |
| Dec 31, 2022 | 42.21 Mn |
| Dec 31, 2021 | 55.59 Mn |
| Dec 31, 2020 | 50.85 Mn |
| Dec 31, 2019 | 52.47 Mn |
| Dec 31, 2018 | 63.91 Mn |
| Dec 31, 2017 | 12.64 Mn |
| Dec 31, 2016 | 6.00 Mn |